FDA
- Status: approved
Runzaozhiyang capsule agent simulation (Runzaozhiyang capsule agent simulation) regulatory status in United States.
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA has authorised it.
Guizhou Tongjitang Pharmaceutical Co.,Ltd is the originator. The local marketing authorisation holder may differ — check the official source linked above.